Blackshaws Road Pharmacy
MediHerb Phellodendron Forte 60 tabs
MediHerb Phellodendron Forte 60 tabs
Couldn't load pickup availability
MediHerb Phellodendron Forte 60 tabs
Pack size: 60 tablets
MediHerb Phellodendron Forte has No Added: Gluten, soya bean, milk, lactose, peanuts, tree nuts, fish, crustacea, corn, egg, sesame seeds, artificial sweeteners, colours or flavours
MediHerb Phellodendron Forte is Suitable for Vegans
Description
Description: MediHerb Phellodendron Forte
Phellodendron Forte contains Phellodendron which is traditionally used in Chinese medicine to relieve diarrhoea.
Indications
Indications: MediHerb Phellodendron Forte
- Phellodendron is an anti-inflammatory
- Phellodendron is traditionally used in Chinese medicine to:
Dose and Administration
Dose and Administration: MediHerb Phellodendron Forte
Adults: 1 tablet 2-4 times daily
Allergen Information
Allergen Information: MediHerb Phellodendron Forte
No Added: Gluten, soya bean, milk, lactose, peanuts, tree nuts, fish, crustacea, corn, egg, sesame seeds, artificial sweeteners, colours or flavours
Suitable for Vegans
Ingredients
Ingredients: MediHerb Phellodendron Forte
Each tablet contains: | |
Phellodendron amurense (Phellodendron) extract | 440mg |
- derived from min. stem bark dry | 8.8g |
- standardised to contain berberine | 200mg |
Excipients
Excipients: MediHerb Phellodendron Forte
Calcium hydrogen phosphate dihydrate, colloidal anhydrous silica, croscarmellose sodium, hydrochloric acid, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycollate.
Warnings, Contraindications and Cautions
Warnings, Contraindications and Cautions: MediHerb Phellodendron Forte
- If diarrhoea persists for more than 6 hours in infants under 6 months, 12 hours in children under 3 years, 24 hours in children aged 3-6 years or 48 hours in adults and children over 6 years, seek medical advice
- Contraindicated during pregnancy, lactation and in patients taking immunosuppressive drugs
- Caution is warranted in betathalassaemia, unconjugated hyperbilirubinaemia and those with obstructed bile ducts
- Until definitive research is available, do not use in jaundiced neonates
- Monitor patients who tend to experience constipation
- Discontinue 7 days prior to general anaesthesia
- If patient symptoms persist, seek additional professional advice